Vaccines, Blood & Biologics
-
Section 8200: Investigational New Drugs (INDs)
-
SOPP 8201: Issuance of and Response to Clinical Hold Letters for Investigational New Drug Applications
Effective Date: April 27, 1999SOPP 8202: Handling IND Submitted with Insufficient Copies
Effective Date: March 8, 2000SOPP 8203: Evaluation of Cost Recovery Requests for Investigational New Drugs and Investigational Device Exemptions
Effective Date: January 15, 2013SOPP 8205: Emergency INDs
Effective Date: October 22, 2007SOPP 8206: Discontinuing Investigational and Related Applications (IRAs)
Effective Date: March 12, 2008
-
-
-







